1-4 of 4
Hilde Demuynck, MD
Close
Sort by
Journal Articles

Anemia and the Use of Erythropoietic-Stimulating Agents with Ruxolitinib in the COMFORT-II Study

Mary Frances McMullin, MD, Claire N. Harrison, DM, FRCP, FRCPath, Dietger Niederwieser, MD, Hilde Demuynck, MD, PhD, Nadja Jäckel, Andres Sirulnik, MD, PhD, Alison Wearver, PhD, Viktoriya Stalbovskaya, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Haifa Kathrin Al-Ali, MD
Journal: Blood
Blood (2011) 118 (21): 5147.
https://doi.org/10.1182/blood.V118.21.5147.5147
Published: 2011
Journal Articles

BMI1 , the Polycomb-Group Gene, Is Recurrently Targeted by Genomic Rearrangements in Progressive B-Cell Leukemia/Lymphoma.

Leila Rouhi, MD, Natalie Put, MD, Thomas Tousseyn, MD, PhD, Julio Finalet Ferreiro, Wim De Kelver, Hilde Demuynck, MD, Johan Verschuere, MD, Ivan Théate, MD, Carmen Vicente, Lucienne Michaux, MD, PhD, Chris De Wolf-Peeters, MD, PhD, Peter Vandenberghe, MD, PhD, Jan Cools, PhD, Iwona Wlodarska, PhD
Journal: Blood
Blood (2009) 114 (22): 1099.
https://doi.org/10.1182/blood.V114.22.1099.1099
Published: 2009
Journal Articles

Gain-of-Function WASP Mutations in Pediatric and Adult Patients with Myelodysplasia or AML.

Karolien Beel, MD, Els Schollen, PhD, An Uyttebroeck, MD, Gregor Verhoef, MD PhD, Hilde Demuynck, MD PhD, Koen Devriendt, MD PhD, Peter Vandenberghe, MD PhD
Journal: Blood
Blood (2006) 108 (11): 4516.
https://doi.org/10.1182/blood.V108.11.4516.4516
Published: 2006
Journal Articles

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Dominique Bron, MD, PhD, Pierre Zachée, MD, Johan Maertens, MD, Koen Theunissen, MD, Augustin Ferrant, MD, PhD, Philippe Martiat, MD, PhD, Chantal Doyen, MD, Luc Noens, MD, Wilfried Schroyens, MD, Dominique Sellesslag, MD, Hilde Demuynck, MD, Rick Schots, MD, PhD, Anne De Meuter, Marc Boogaerts, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5046.
https://doi.org/10.1182/blood.V104.11.5046.5046
Published: 2004